Up next
Arizona doctor’s husband spotted for the first time after allegedly leaving 2-year-old daughter in hot car for three hours.
Author
Internewscast
FacebookXRedditPinterest
The US Food and Drug Administration (FDA) has approved the first ever life-saving nasal spray for the treatment of severe allergic reactions. The approval, announced Friday, offers an alternative to the millions of people who until now have had to rely on injections—known to most as EpiPens. The nasal spray, which will be sold under the brand name Neffy, is designed to be used in place of auto-injectable pens filled with epinephrine (aka adrenaline, a hormone that can be used in drug form to treat allergic emergencies). The new drug only requires a single spray into one nostril and is approved for use in adults and children weighing over 66 pounds.
“The approval we received today offers the initial epinephrine option for treating anaphylaxis that does not require an injection,” stated Kelly Stone, MD, PhD, who serves as the associate director of the Division of Pulmonology, Allergy and Critical Care at the FDA. “Anaphylaxis is a severe condition that can be life-threatening, and certain individuals, especially children, might hesitate or refuse treatment because of their fear of injections.”
Anaphylaxis—the life-threatening condition that can occur within seconds of encountering an allergen—may occur in one in 50 Americans, according to the Asthma and Allergy Foundation of America. Stats are hard to come by, however, and some believe the number could be as high as one in 20 Americans. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of anaphylaxis. As a result, neffy provides an important treatment option and addresses an unmet need,” Dr. Stone said in the statement.
In September 2023, the FDA declined to approve the drug and requested additional testing, despite recommendations from independent experts, according to Reuters. Neffy has been tested in 175 healthy adults without anaphylaxis, due to ethical concerns. The concentration of epinephrine in the blood after administration was comparable to those who received an EpiPen injection instead. Neither the FDA, nor the makers of Neffy, ARS Pharmaceuticals, have announced when the drug will be available for purchase.
This comes as welcome news to anyone who personally deals with life-threatening allergies—or knows or cares for someone who does. And, thanks to its new method of delivery, Neffy may prove less intimidating to use at various life and age stages than traditional needle-injections pens.
FacebookXRedditPinterest
You May Also Like
- Health
Important Information About Parvovirus for Parents of School-Going Kids
Just in time for back-to-school season, parvovirus B19—sometimes called “slapped cheek” syndrome—is…
- Internewscast
- August 21, 2024
- Health
“The Surprising Culprit Behind the Rising Wave of New Dementias Affecting Every Household”
A new study has added fuel to concerns that America could face…
- Internewscast
- August 21, 2024
- Health
Doctor advises patients not to ignore common symptoms and visit GP immediately
A GP has warned individuals to never dismiss certain symptoms as normal…
- Internewscast
- August 21, 2024
- Health
“Overcoming Flu-Induced Pain and Steroid Dependence to Find Hope”
Struggling to cope with chronic pain and waking up to six times…
- Internewscast
- August 21, 2024
- Health
Discover how frequently you should exercise to reduce the chances of developing dementia, stroke, and Parkinson’s, as shown in a recent study.
It can often feel impossible trying to juggle a career and social…
- Internewscast
- August 21, 2024
- Health
Expert warns that feeling of ‘pins and needles’ may indicate severe and disabling conditions
Boots’ health experts have issued a warning, urging people to seek medical…
- Internewscast
- August 21, 2024
- Health
Methods Used by Politicians to Stay Fit for Office After Robert Jenrick Reveals Ozempic Use
Tory leadership contender Robert Jenrickthis week revealed how he took weight-loss drug…
- Internewscast
- August 21, 2024
- Health
Macy Gray experiences health scare with Ozempic live on TV
Macy Gray was rushed to the hospital in a wheelchair after her…
- Internewscast
- August 21, 2024
- Health
Improving Joint Mobility Could Help You Live Longer, Suggests Recent Research
Joint mobility—the ability to move a joint through its full range of…
- Internewscast
- August 21, 2024
- Health
Survey shows nearly half of NHS patients’ health deteriorates during hospital admission wait
More than four in ten NHS patients have seen their health get…
- Internewscast
- August 22, 2024
- Health
Medical Professional Describes Brain Condition with ‘Hidden Cavities’ and Lack of Apparent Signs
Cavernomas, which can form in the brain or spinal cord, are almost…
- Internewscast
- August 22, 2024
- Health
Mapping of COVID-19 hotspots in the UK – Complete list showing the city with the highest number of confirmed cases
Mpox has been declared an international emergency by the World Health Organisation…
- Internewscast
- August 21, 2024